Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号

Headquarter Address: 8888 Lvyou Road, Jinan, Shandong 250104, CHINA Powered by www.300.cn

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

Release time:
2021-12-20
Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

Release time:
2021-12-20
Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

Release time:
2021-12-20
Abiraterone Acetate Tablets exported to US

Abiraterone Acetate Tablets exported to US

Release time:
2020-01-20
The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA

The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA

Release time:
2019-12-09
Qilu Pharmaceutical Ranks No. 8th among Top 100 Chinese Pharmaceutical Companies

Qilu Pharmaceutical Ranks No. 8th among Top 100 Chinese Pharmaceutical Companies

Release time:
2019-08-30
Qilu Pharmaceutical recognized as Top 3 domestic R&D pharmaceutical company of 2019

Qilu Pharmaceutical recognized as Top 3 domestic R&D pharmaceutical company of 2019

Release time:
2019-06-22
Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States

Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States

Release time:
2020-05-20
Qilu Pharma Announces Launch of a Generic Version of Cialis ® in the United States

Qilu Pharma Announces Launch of a Generic Version of Cialis ® in the United States

Release time:
2019-03-06
Piperacillin Sodium/Tazobactam Sodium exported to US

Piperacillin Sodium/Tazobactam Sodium exported to US

Release time:
2018-12-21